Literature DB >> 16450084

Tumor staging using whole-body high-resolution 16-channel PET-CT: does additional low-dose chest CT in inspiration improve the detection of solitary pulmonary nodules?

K U Juergens1, M Weckesser, L Stegger, C Franzius, M Beetz, O Schober, W Heindel, D Wormanns.   

Abstract

For optimal image fusion between CT and F-18-FDG-PET, the acquisition of CT images is performed in mild expiratory suspension, which might compromise the detection of lung metastases. This study aimed at evaluating the influence of expiration on the detection of solitary pulmonary nodules (SPN) and at assessing if additional inspiratory low-dose CT (I-LDCT) of the chest can improve the detection of potential lung metastases performing whole-body 16-channel PET-CT. Sixty-six patients with malignant tumors underwent PET-CT: contrast-enhanced CT was acquired during mild expiration and was used for fusion with PET images; additionally, chest I-LDCT was performed at deep inspiration. Two radiologists reported all SPN detected at I-LDCT and the expiratory CT scan independently. Overall, 53% of 128 SPN (mean: 3.8+/-0.2 mm) were detected at both respiratory states: 51 SPN only at I-LDCT, and 9 nodules only at expiratory CT. Of the SPN, 117/128 were classified as certain; 45 of those were additionally detected at I-LDCT, and 6 nodules at expiratory CT. A 100% detection rate was reached in SPN >4 mm at I-LDCT versus >8 mm at expiratory CT (all P<0.001). Additional I-LDCT of the chest significantly improves the detection of SPN at whole-body F-18-FDG-PET-CT and thus is recommended as part of the standard protocol for oncological patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16450084     DOI: 10.1007/s00330-005-0080-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  26 in total

1.  Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation.

Authors:  D F Yankelevitz; A P Reeves; W J Kostis; B Zhao; C I Henschke
Journal:  Radiology       Date:  2000-10       Impact factor: 11.105

2.  Volumetric measurements of pulmonary nodules at multi-row detector CT: in vivo reproducibility.

Authors:  Dag Wormanns; Gerhard Kohl; Ernst Klotz; Anke Marheine; Florian Beyer; Walter Heindel; Stefan Diederich
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

3.  Pulmonary nodule detection: low-dose versus conventional CT.

Authors:  H Rusinek; D P Naidich; G McGuinness; B S Leitman; D I McCauley; G A Krinsky; K Clayton; H Cohen
Journal:  Radiology       Date:  1998-10       Impact factor: 11.105

4.  Does 2-year stability imply that pulmonary nodules are benign?

Authors:  D F Yankelevitz; C I Henschke
Journal:  AJR Am J Roentgenol       Date:  1997-02       Impact factor: 3.959

5.  ACR Appropriateness Criteria® screening for pulmonary metastases.

Authors:  Tan-Lucien H Mohammed; Aqeel Chowdhry; Gautham P Reddy; Judith K Amorosa; Kathleen Brown; Debra Sue Dyer; Mark E Ginsburg; Darel E Heitkamp; Jean Jeudy; Jacobo Kirsch; Heber MacMahon; J Anthony Parker; James G Ravenel; Anthony G Saleh; Rakesh D Shah
Journal:  J Thorac Imaging       Date:  2011-02       Impact factor: 3.000

6.  Screening for early lung cancer with low-dose spiral CT: prevalence in 817 asymptomatic smokers.

Authors:  Stefan Diederich; Dag Wormanns; Michael Semik; Michael Thomas; Horst Lenzen; Nikolaus Roos; Walter Heindel
Journal:  Radiology       Date:  2002-03       Impact factor: 11.105

7.  Unknown primary tumors: detection with dual-modality PET/CT--initial experience.

Authors:  Andreas Gutzeit; Gerald Antoch; Hilmar Kühl; Thomas Egelhof; Markus Fischer; Elke Hauth; Susanne Goehde; Andreas Bockisch; Jörg Debatin; Lutz Freudenberg
Journal:  Radiology       Date:  2004-11-24       Impact factor: 11.105

8.  PET/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management.

Authors:  Zohar Keidar; Nissim Haim; Luda Guralnik; Mirjana Wollner; Rachel Bar-Shalom; Alon Ben-Nun; Ora Israel
Journal:  J Nucl Med       Date:  2004-10       Impact factor: 10.057

9.  Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.

Authors:  Didier Lardinois; Walter Weder; Thomas F Hany; Ehab M Kamel; Stephan Korom; Burkhardt Seifert; Gustav K von Schulthess; Hans C Steinert
Journal:  N Engl J Med       Date:  2003-06-19       Impact factor: 91.245

10.  Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology.

Authors:  Gerald Antoch; Florian M Vogt; Lutz S Freudenberg; Fridun Nazaradeh; Susanne C Goehde; Jörg Barkhausen; Gerlinde Dahmen; Andreas Bockisch; Jörg F Debatin; Stefan G Ruehm
Journal:  JAMA       Date:  2003-12-24       Impact factor: 56.272

View more
  9 in total

1.  Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT.

Authors:  W De Wever; S Ceyssens; L Mortelmans; S Stroobants; G Marchal; J Bogaert; J A Verschakelen
Journal:  Eur Radiol       Date:  2006-05-09       Impact factor: 5.315

2.  Radiation dose reduction through combining positron emission tomography/computed tomography (PET/CT) and diagnostic CT in children and young adults with lymphoma.

Authors:  Zhihua Qi; Erica L Gates; Maureen M O'Brien; Andrew T Trout
Journal:  Pediatr Radiol       Date:  2017-10-28

3.  Additional value of integrated PET-CT in the detection and characterization of lung metastases: correlation with CT alone and PET alone.

Authors:  W De Wever; L Meylaerts; L De Ceuninck; S Stroobants; J A Verschakelen
Journal:  Eur Radiol       Date:  2006-10-03       Impact factor: 5.315

Review 4.  Dosimetry of FDG PET/CT and other molecular imaging applications in pediatric patients.

Authors:  Michael J Gelfand
Journal:  Pediatr Radiol       Date:  2008-12-16

5.  Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology.

Authors:  J Stauss; C Franzius; T Pfluger; K U Juergens; L Biassoni; J Begent; R Kluge; H Amthauer; T Voelker; L Højgaard; S Barrington; S Hain; T Lynch; K Hahn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08       Impact factor: 9.236

6.  Diagnostic value of PET/CT for the staging and restaging of pediatric tumors.

Authors:  Margit Kleis; Heike Daldrup-Link; Katherine Matthay; Robert Goldsby; Ying Lu; Tibor Schuster; Carole Schreck; Philip W Chu; Randall A Hawkins; Benjamin L Franc
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-22       Impact factor: 9.236

7.  Whole-body MRI at 1.5 T and 3 T compared with FDG-PET-CT for the detection of tumour recurrence in patients with colorectal cancer.

Authors:  G P Schmidt; A Baur-Melnyk; A Haug; S Utzschneider; C R Becker; R Tiling; M F Reiser; K A Hermann
Journal:  Eur Radiol       Date:  2009-02-04       Impact factor: 5.315

8.  Diagnostic efficacy of whole-body diffusion-weighted imaging in the detection of tumour recurrence and metastasis by comparison with 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography or computed tomography in patients with gastrointestinal cancer.

Authors:  Jiaying Gong; Wuteng Cao; Zhanwen Zhang; Yanhong Deng; Liang Kang; Pan Zhu; Zhengjun Liu; Zhiyang Zhou
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-11-17

9.  Diagnosing Lung Nodules on Oncologic MR/PET Imaging: Comparison of Fast T1-Weighted Sequences and Influence of Image Acquisition in Inspiration and Expiration Breath-Hold.

Authors:  Nina F Schwenzer; Ferdinand Seith; Sergios Gatidis; Cornelia Brendle; Holger Schmidt; Christina A Pfannenberg; Christian laFougère; Konstantin Nikolaou; Christina Schraml
Journal:  Korean J Radiol       Date:  2016-08-23       Impact factor: 3.500

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.